Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteonectin-null mutation compromises osteoblast formation, maturation, and survival.

Anne M Delany1, Ivo Kalajzic, Amy D Bradshaw

  • 1Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105, USA. adelany@stfranciscare.org

Endocrinology
|May 15, 2003
PubMed
Summary

Osteonectin (SPARC) is crucial for bone health. Mice lacking osteonectin show impaired osteoblast development and bone formation, highlighting its role in maintaining bone mass and remodeling.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A NOTCH2 pathogenic variant alters the osteoblast and vascular cell transcriptome of mouse femurs.

Bone·2026
Same author

Inactivation of Hes1 in Skeletal Undifferentiated Cells Increases Bone Volume.

Endocrinology·2026
Same author

Psychological stress and myocardial extracellular matrix remodeling- a pathologic synergy.

Biochemical pharmacology·2026
Same author

Mechanical stretch reduces fibroblast activation in heart failure with reduced ejection fraction.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2025
Same author

miR-433 targets BMP and Indian hedgehog signaling to coordinate murine postnatal growth plate dynamics.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025
Same author

A novel variant of NOTCH2 causes skeletal fragility.

Bone·2025

Area of Science:

  • Bone Biology
  • Cellular Differentiation
  • Biochemistry

Background:

  • Osteonectin (SPARC) is a key noncollagenous protein in bone.
  • Its precise role in bone remodeling and osteoblast function requires further elucidation.

Purpose of the Study:

  • To investigate the cellular mechanisms underlying bone defects in osteonectin-null mice.
  • To determine osteonectin's impact on osteoblast precursor development, differentiation, and survival.

Main Methods:

  • Comparative analysis of bone marrow stromal cells and osteoblasts from wild-type and osteonectin-null mice.
  • Assessment of cell proliferation, differentiation markers (osteocalcin, mineralized nodule formation), adipogenesis markers (adipsin, C/EBPδ), and stress susceptibility.

Main Results:

Related Experiment Videos

  • Osteonectin-null mice exhibit reduced osteoblast numbers and bone formation rates.
  • Marrow stroma from null mice contains fewer osteoblastic precursors.
  • Null osteoblasts show impaired differentiation, reduced mineralization, and altered gene expression (osteocalcin, PTH response).
  • Osteonectin-null cells display increased adipogenesis and susceptibility to stress.

Conclusions:

  • Osteonectin is essential for proper osteoblast formation, maturation, and survival.
  • Its absence leads to impaired bone remodeling and increased adipocyte differentiation.
  • These findings underscore osteonectin's critical role in maintaining skeletal integrity.